Literature DB >> 5773217

Monocrotaline-induced pulmonary hypertension and p-chlorophenylalanine (PCPA).

L Carrillo, D M Aviado.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5773217

Source DB:  PubMed          Journal:  Lab Invest        ISSN： 0023-6837            Impact factor:   5.662


× No keyword cloud information.
  5 in total

Review 1.  One hundred years of research in the pathogenesis of pulmonary hypertension.

Authors:  Ari Zaiman; Iwona Fijalkowska; Paul M Hassoun; Rubin M Tuder
Journal:  Am J Respir Cell Mol Biol       Date:  2005-11       Impact factor: 6.914

2.  Physicochemical and metabolic basis for the differing neurotoxicity of the pyrrolizidine alkaloids, trichodesmine and monocrotaline.

Authors:  R J Huxtable; C C Yan; S Wild; S Maxwell; R Cooper
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

Review 3.  Perspective: pathobiological paradigms in pulmonary hypertension, time for reappraisal.

Authors:  Rubin M Tuder; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-03-18       Impact factor: 5.464

4.  Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension.

Authors:  J M Kay; P M Keane; K L Suyama; D Gauthier
Journal:  Thorax       Date:  1982-02       Impact factor: 9.139

5.  A process-based review of mouse models of pulmonary hypertension.

Authors:  Mita Das; Joshua Fessel; Haiyang Tang; James West
Journal:  Pulm Circ       Date:  2012-10       Impact factor: 3.017
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.